Revolutionizing Nylon Production: The Promise of Overlooked Plant Materials
A new sustainable method for nylon production may transform the industry by utilizing plant materials that have long been discarded as waste.
Editorial Staff Jun 14
Medicine
Latest Medicine stories from Life.
Groundbreaking Study Unveils Complete Connectome of Fruit Fly's Nervous System
A major advancement in neuroscience has emerged with the publication of the first complete wiring diagram of the fruit fly's brain and spinal cord, led by Harvard and Princeton researchers.
Editorial Staff Jun 14
FDA Approves Sanofi's Diabetes Drug for Pediatric Patients Amid Controversy
The FDA has granted approval for a Sanofi diabetes treatment aimed at young patients, following a contentious internal dispute within the agency.
Editorial Staff Jun 13
Dawn Zuidgeest-Craft: Pursuing Medicine at 73
At 73, Dawn Zuidgeest-Craft embarks on a remarkable journey into medical residency, challenging age norms in the field of medicine.
Editorial Staff Jun 13
Trump Administration Moves to Close Medicare Drug Price Negotiation Loophole
In a recent development, the Trump administration is taking measures to address a loophole in the negotiations surrounding Medicare drug prices.
Editorial Staff Jun 12
Blood Cancer United Takes Action to Acquire Discontinued Drug Luvelta for Patients
In an unusual decision, Blood Cancer United, a nonprofit organization, is purchasing the last supplies of Luvelta, a discontinued investigational cancer drug.
Editorial Staff Jun 12
Advancements in Cryo-Electron Microscopy Open New Avenues for Research
Recent developments in cryo-electron microscopy techniques enable the observation of materials in organic solvents, potentially transforming the study of various advanced technologies.
Editorial Staff Jun 12
Exploring New Frontiers in Obesity Medications and Peptide Treatments
The landscape of obesity medications is evolving, with new drugs entering the market and peptides gaining traction in treatment protocols. The FDA's decisions will be pivotal.
Editorial Staff Jun 11
Novartis Reinforces Commitment to Molecular Glue Approach
In recent biotech developments, Novartis has reaffirmed its focus on molecular glue strategies amidst rising drug costs for seniors and advancements in leukemia treatments.
Editorial Staff Jun 11
Medicare Advantage Payment System Creates Imbalance in Drug Plan Competition
The dynamics of competition among Medicare Part D plans are increasingly affected by the payment structure of Medicare Advantage plans, raising concerns about fairness.
Editorial Staff Jun 11
Federal Actions Highlight Impact of Rare Outcomes on Vaccine and Gender Care Perceptions
Recent developments, including a federal memo on alleged vaccine-related deaths and the establishment of a detransition clinic, illustrate how rare outcomes can shape public views on vaccine safety and gender care.
Editorial Staff Jun 11
The Rising Costs of Publishing: A Case Study from Nature Medicine
Elizabeth Selvin reflects on the stark contrast in publication fees at Nature Medicine between 2025 and 2026, highlighting a significant financial burden for researchers.
Editorial Staff Jun 11
Concerns Mount Over Drug Shortages and Pricing in Europe Amid U.S. Scrutiny
A recent analysis highlights a troubling increase in drug shortages and pricing pressures in Europe, with U.S. authorities intensifying their scrutiny.
Editorial Staff Jun 10
European Nations Navigate Drug Pricing Challenges Amid U.S. Influence
As the U.S. observes the situation, European countries are developing varied approaches to drug pricing, which could have significant implications for the pharmaceutical sector and patient access.
Editorial Staff Jun 10
Novo's Disappointment with Former Pfizer Rival Drug
Novo Nordisk expresses disappointment with a drug it previously contested with Pfizer. Meanwhile, Revolution and Tango show encouraging cancer results, and Incyte acquires a bleeding disorder treatment.
Editorial Staff Jun 8
Lilly Shares New Insights on Obesity Drug Retatrutide Amid Industry Developments
Lilly has released additional data regarding the safety and tolerability of its obesity drug retatrutide, contributing to ongoing discussions in the pharmaceutical sector.
Editorial Staff Jun 8
Concerns Arise Over Efficacy of Boehringer’s Obesity Treatment
Recent findings suggest that while Boehringer Ingelheim’s obesity drug may effectively reduce liver fat, its overall weight loss results are less compelling.
Editorial Staff Jun 7
Highlights from the American Diabetes Association Conference: Hormone Receptors and Obesity Treatment
The American Diabetes Association's annual conference in New Orleans showcased new insights, including developments in hormone receptors and a monthly obesity drug.
Editorial Staff Jun 6
Pfizer's Obesity Drug Shows Promise in Midstage Study
Recent findings from a midstage study indicate that Pfizer's obesity treatment, obtained from Metsera, may be effective with monthly dosing.
Editorial Staff Jun 6
Youth Discontent Grows Amid India’s Medical Exam Cancellation
The recent cancellation of medical entrance tests affecting over 2 million candidates has ignited frustration towards Prime Minister Narendra Modi's administration.
Editorial Staff Jun 6